Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Treatment of imported malaria in adults: A multicentre study in France
QJM - Monthly Journal of the Association of Physicians, Volume 98, No. 10, Year 2005
Notification
URL copied to clipboard!
Description
Background: Data about anti-malarial drugs prescription practices in Europe and the safety of imported malaria treatments are scanty. In 1999, a French consensus development conference published guidelines for the prevention and treatment of imported P. falciparum malaria. The impact of these guidelines has not been evaluated. Aim: To investigate the impact of these guidelines on the prescription of anti-malarials, and to evaluate the incidence of acute drug events (ADEs) leading to discontinuation of treatment. Design: Cross-sectional survey. Methods: Members of the medical staff i n 14 French infectious and tropical disease wards completed a standardized form for each patient treated for imported malaria in 2001. A propensity score matching technique was used to estimate the risk of ADEs leading to discontinuation of the regimen. Results: In the 474 patients studied, quinine was the first-line anti-malarial most often prescribed. Only 3% of patients received halofantrine. Mefloquine was associated with a RR of 4.9 (95%CI 3.2-7.4, p<0.00001) risk of discontinuation of treatment due to ADEs. Discussion: The very limited use of halofantrine indicates that the main practice recommendations of the guidelines have been taken into account. Mefloquine was associated with a substantial risk of discontinuing the treatment because of ADEs. This is a serious limitation for the use of mefloquine in the treatment of out-patients with imported malaria. © The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved.
Authors & Co-Authors
Ranque, S.
France, Marseille
Hôpital Nord Ap-hm
France, Paris
Inserm
Malvy, Denis Jean Marie
Unknown Affiliation
Adehossi, Eric O.
France, Marseille
Hôpital Nord Ap-hm
Laganier, Rémi
Unknown Affiliation
Tissot-Dupont, Hervé
Unknown Affiliation
Durant, Jacques M.
Unknown Affiliation
Stahl, Jean Paul
Unknown Affiliation
Gaíllat, Jacques
Unknown Affiliation
Sotto, Albert
Unknown Affiliation
Cazorla, Céline
Unknown Affiliation
Brouqui, Philippe
France, Marseille
Hôpital Nord Ap-hm
Delmont, Jean Pierre
France, Marseille
Hôpital Nord Ap-hm
Receveur, Marie Catherine
Unknown Affiliation
Beytout, Jean
Unknown Affiliation
Gourdon, Florence
Unknown Affiliation
Laurichesse, Henri A.A.
Unknown Affiliation
Brion, Jean Paul
Unknown Affiliation
Biron, François
Unknown Affiliation
Boibieux, André
Unknown Affiliation
Peyramond, Dominique
Unknown Affiliation
Badiaga, Sékéné
Unknown Affiliation
Parola, Philippe
Unknown Affiliation
Ravaux, Isabelle
Unknown Affiliation
Stein, Andréas
Unknown Affiliation
Reynès, Jacques M.
Unknown Affiliation
Dellamonica, Pierre
Unknown Affiliation
Pradier, Christian
Unknown Affiliation
Roger, Pierre‑Marie
Unknown Affiliation
Berthelot, Philippe
Unknown Affiliation
Frésard, Anne
Unknown Affiliation
Lucht, Frederick R.
Unknown Affiliation
Statistics
Citations: 11
Authors: 31
Affiliations: 2
Identifiers
Doi:
10.1093/qjmed/hci110
ISSN:
14602725
Research Areas
Health System And Policy
Infectious Diseases
Study Design
Cross Sectional Study
Cohort Study
Case-Control Study
Study Approach
Quantitative